RNA m<sup>6</sup>A modification is a driver and therapeutic target in gastric cancer. [PDF]
Chen Q, Lu H, Li D, Liu T.
europepmc +1 more source
Targeting lactylation in a novel metabolic-epigenetic-inflammatory axis mitigates inflammation and promotes healing following corneal injury. [PDF]
Guan Y +12 more
europepmc +1 more source
Intratumor microbiota Delftialacustiris correlated with METTL3 to control development of papillary thyroid carcinoma. [PDF]
Qiu K, Xie Q, Zeng D, Huang Y, Lin T.
europepmc +1 more source
Magnesium ions facilitate osteogenic differentiation and intervertebral fusion <i>via</i> m6A methylation of RhoA mRNA. [PDF]
Xu H +19 more
europepmc +1 more source
The METTL3-IGF2BP3 axis drives osteosarcoma progression by enhancing ID1 mRNA stability. [PDF]
Shu R +8 more
europepmc +1 more source
METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability. [PDF]
Zhu D, Shen R, Li M.
europepmc +1 more source
Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway. [PDF]
Zhu J +10 more
europepmc +1 more source
Robust loading and delivery of functional small RNAs <i>via</i> protein N-myristoylation-induced small extracellular vesicles. [PDF]
Wang H +9 more
europepmc +1 more source
ELABELA targets the METTL3/PI3K/AKT axis to enhance trophoblast invasion in early-onset preeclampsia. [PDF]
Wang L +5 more
europepmc +1 more source
METTL3 inhibition alleviates neuroinflammation and apoptosis by reducing ETV4 m6A modification. [PDF]
He D +8 more
europepmc +1 more source

